TCOT
Trust Company of Toledo Portfolio holdings
AUM
$907M
1-Year Return
17.44%
This Quarter Return
+4.13%
1 Year Return
+17.44%
3 Year Return
+72.18%
5 Year Return
+123.71%
10 Year Return
+243.97%
AUM
$691M
AUM Growth
+$51.8M
(+8.1%)
Cap. Flow
+$34.9M
Cap. Flow
% of AUM
5.05%
Top 10 Holdings %
Top 10 Hldgs %
35.92%
Holding
237
New
11
Increased
128
Reduced
51
Closed
5
Top Buys
| 1 |
Microsoft
MSFT
|
$2.1M |
| 2 |
Apple
AAPL
|
$2.08M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$1.57M |
| 4 |
Philip Morris
PM
|
$1.52M |
| 5 |
iShares Russell Mid-Cap ETF
IWR
|
$1.38M |
Top Sells
| 1 |
3M
MMM
|
$369K |
| 2 |
Eastman Chemical
EMN
|
$329K |
| 3 |
Starbucks
SBUX
|
$277K |
| 4 |
Dentsply Sirona
XRAY
|
$254K |
| 5 |
Air Products & Chemicals
APD
|
$219K |
Sector Composition
| 1 | Technology | 31.21% |
| 2 | Healthcare | 14.67% |
| 3 | Financials | 10.77% |
| 4 | Industrials | 9.21% |
| 5 | Consumer Discretionary | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Canadian Imperial Bank of Commerce
CM
$73.6B
| $201K | 0.03% |
4,230
| – | – |
|
|
AUTL
227
Autolus Therapeutics
AUTL
$386M
| $126K | 0.02% |
36,265
| – | – |
|
228
Trevi Therapeutics
TRVI
$880M
| $109K | 0.02% |
36,502
| – | – |
|
|
IRD
229
Opus Genetics, Inc. Common Stock
IRD
$76.7M
| $47.4K | 0.01% |
30,963
| – | – |
|
230
Lineage Cell Therapeutics
LCTX
$274M
| $33.7K | ﹤0.01% |
33,795
| – | – |
|
231
Great Elm Group
GEG
$87M
| $27K | ﹤0.01% |
15,000
| – | – |
|
|
VIRX
232
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $6.7K | ﹤0.01% |
12,317
| – | – |
|
233
Canadian National Railway
CNI
$60.4B
| – | – |
-1,598
| Closed | -$210K |
|
234
Corteva
CTVA
$49.3B
| – | – |
-3,610
| Closed | -$208K |
|
|
235
Eastman Chemical
EMN
$7.88B
| – | – |
-3,279
| Closed | -$329K |
|
236
Rayonier
RYN
$4.05B
| – | – |
-6,810
| Closed | -$215K |
|
|
237
Dentsply Sirona
XRAY
$2.86B
| – | – |
-7,655
| Closed | -$254K |
|